Acrivon Therapeutics, Inc. (ACRV) Operating income 2021–2025
Acrivon Therapeutics, Inc. (ACRV) annual operating income history from SEC filings — each fiscal year as reported.
-$84.1MFY2025 · since FY2021: -$16.2M → -$84.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.1M | +5.7% |
| FY2024 | -$89.2M | -32.9% |
| FY2023 | -$67.1M | -105.5% |
| FY2022 | -$32.7M | -101.8% |
| FY2021 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACRV financial trends
ACRV RevenueACRV Net incomeACRV Net marginACRV Gross profitACRV Gross marginACRV Operating marginACRV Operating cash flowACRV Free cash flowACRV Capital expendituresACRV Return on equityACRV Stock buybacksACRV Dividends paidACRV Total assetsACRV Total liabilitiesACRV Shareholders’ equityACRV overview →